Syndax Pharmaceuticals SNDX Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Syndax Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Syndax Pharmaceuticals's change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Syndax Pharmaceuticals's change in other assets?
- Syndax Pharmaceuticals (SNDX) reported change in other assets of -$7.84M in Q1 2026.
- How has Syndax Pharmaceuticals's change in other assets changed year-over-year?
- Syndax Pharmaceuticals's change in other assets decreased by 30.8% year-over-year, from -$5.99M to -$7.84M.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.